切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2026年會
        • 摘要
      • 2026半年會
        • 摘要
      • 2025年會 (UAA)
        • 摘要
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 熱門媒體

熱門媒體
(
  • 最新
)

熱門媒體

(
  • 最新
)
MP098: Different laparoscopic partial cystectomy approach for bladder leiomyoma
1871 觀看
NDP08: Elective radical prostatectomy for huge prostate cancer with bilateral obstructive uropathy、rectal invasion and oligometastasis of bone
1870 觀看
MP087: Outcomes of laparoscopic and robotic nephroureterectomy approaches in patients with T3 and T4 upper tract urothelial carcinoma in CMUH
1870 觀看
PD4-2: Tumor-originated exosomal prothymosin-α triggers muscle wasting in bladder cancers
1869 觀看
MP027: Robotic partial nephrectomy for > 4cm renal cell carcinoma: single center experience
1869 觀看
NDP037: Lower urinary tract symptoms caused by Müllerian duct cyst: A case report
1868 觀看
MP01-10: MCTP1 promotes SNAI1-driven neuroendocrine differentiation and epithelial-to-mesenchymal transition of prostate cancer enhancement by ZBTB46/FOXA2/HIF1A
1868 觀看
PD8-6: Regular cystoscopy-assisted bladder toilet is beneficial in catheter-associated urinary tract infection
1867 觀看
MP021: Real world experience of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
1867 觀看
MP07-10: Hypertension as a risk factor for urinary retention in the acute stage of the middle cerebral artery stroke
1867 觀看
MP034: Comparison between complete response of trimodality therapy and neoadjuvant chemotherapy with radical cystectomy in muscle invasive bladder cancer - CMUH experience
1865 觀看
PD02-3: Association between statin use and clinical outcomes in patients with de novo metastatic prostate cancer: A propensity score-weighted analysis
1865 觀看
MP083: An immune checkpoint inhibitor as neoadjuvant therapy in patients with bladder urothelial carcinoma: preliminary experiences in a single institute
1863 觀看
MP15: Laser Flow Cytometry UF-1000i is useful in predicting therapeutic outcomes in women with uncomplicated urinary tract infections
1863 觀看
MP30: The study of growth inhibition and MDR modulation of bladder cancer by ellagic acid combination with chemotherapeutics
1862 觀看
PD05-2: Effect of nocturia in patients with different severity of obstructive sleep apnea on polysomnography
1862 觀看
MP066: Infection after transrectal ultrasound-guided prostate biopsy - rate and contributing factors at a regional hospital
1861 觀看
PD5-1: Using the novel “structural equation modeling” to analyze factors and pathways on the development of uric acid nephrolithiasis
1860 觀看
NDP033: Radium-223 for mCRPC: Real-world experience of a single-center
1859 觀看
PD07-1: High Transaldolase 1 (TALDO1) expression predicts poor survival of upper tract urothelial carcinoma patients
1858 觀看
PD02-5: Intracavernous injection of autologous platelet-rich plasma ameliorated hyperlipidemia-associated erectile dysfunction in a rat model
1858 觀看
PD04-2: Optimal sequencing treatment in castration resistance prostate cancer—A retrospective study in Kaohsiung Chang Gung Memorial Hospital
1858 觀看
MP36: Evaluation of the impact of shock wave lithotripsy on kidneys using neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and 3-nitrotyrosine
1857 觀看
PD04-02: Overall survival with Darolutamide versus placebo in combination with androgen-deprivation therapy and Docetaxel for metastatic hormone-sensitive prostate cancer in the phase 3 ARASENS trial
1857 觀看
  • <
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • >
/ 163
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw